Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management
Stephen M. Ansell
American Journal of Hematology (2022) Vol. 97, Iss. 11, pp. 1478-1488
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial
Paul J. Bröckelmann, Ina Bühnen, Julia Meißner, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 6, pp. 1193-1199
Open Access | Times Cited: 53
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
Angie Mae Rodday, Susan K. Parsons, Jenica N. Upshaw, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 11, pp. 2076-2086
Open Access | Times Cited: 25
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD
Chiara Rusconi, Angelica Barone, Andrea Visentin, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-9
Closed Access
Combination of Brentuximab Vedotin and Pembrolizumab as Salvage Treatment Before Autologous Stem Cell Transplantation and Maintenance in Patients with Relapsed/Refractory Hodgkin Lymphoma
Hanne Massa, Fulvio Massaro, Marie Maerevoet
Biomedicines (2025) Vol. 13, Iss. 2, pp. 252-252
Open Access
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
Shiliang Ge, Kylie Lepic, R. Bhindi, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 118-118
Open Access
Can 18F-FDG PET/CT Metabolic Tumor Volume Contribute to Better Prognostication in Pediatric Hodgkin's Lymphoma?
Sangeetha Ramdas, Saumya Sara Sunny, Hema Nalapullu Srinivasan, et al.
Indian Journal of Medical and Paediatric Oncology (2025)
Open Access
How to Preserve Fertility in Reproductive-Age Women with Cancer
Sébastien Jaeck, Chloé Depuydt, Valérie Bernard, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1912-1912
Open Access
Association between Epstein‐Barr virus LMP‐1 and Hodgkin lymphoma LMP‐1 mechanisms in Hodgkin lymphoma development
Leonam Oliver Durval Oliveira, Igor Brasil Costa, Juarez Antônio Simões Quaresma
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
Rebecca Masel, Megan E. Roche, Ubaldo Martinez‐Outschoorn
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101514-101514
Closed Access | Times Cited: 8
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
Alessandro Cellini, Federico Scarmozzino, Francesco Angotzi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
Vasileios Georgoulis, Alexandra Papoudou‐Bai, Alexandros Makis, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 862-862
Open Access | Times Cited: 6
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study
Katharina Kriegsmann, Max Bittrich, Sandra Sauer, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 50, Iss. 5, pp. 403-416
Open Access | Times Cited: 6
The Impact of Bleomycin Deficit on Survival in Hodgkin's Lymphoma Patients: A Retrospective Study
Luiz Ricardo Soldi, Diogo Henrique Rabelo, Paulo Silva, et al.
Cancer Treatment and Research Communications (2024), pp. 100790-100790
Open Access | Times Cited: 1
The causal effect of adipose tissue on Hodgkin’s lymphoma: two-sample Mendelian randomization study and validation
Lihua Wu, Fei Liao, Xiangli Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020
Armin Aslani, Soroush Morsali, Seyed Ehsan Mousavi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Unravelling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
Vasileios Georgoulis, Alexandra Papoudou‐Bai, Alexandros Makis, et al.
(2023)
Open Access | Times Cited: 4
Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
Patrick Greve, Auke Beishuizen, Melanie M. Hagleitner, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis
Sulaiman Mohammed Alnasser, Khalid Saad Alharbi, Ali F. Almutairy, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2855-2855
Open Access | Times Cited: 4
Chemotherapy’s effects on autophagy in the treatment of Hodgkin’s lymphoma: a scoping review
Roro Wahyudianingsih, Ardo Sanjaya, Timothy Jonathan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Evaluación del tratamiento de linfoma de Hodgkin con esquema ABVD en Chile
María Elena Cabrera C, Bárbara Puga, Vivianne Torres, et al.
Revista médica de Chile (2019) Vol. 147, Iss. 4, pp. 437-443
Open Access | Times Cited: 8
O DIAGNÓSTICO PRECOCE EM PACIENTES PORTADORES DE LINFOMA DE HODGKIN E NÃO HODGKIN: UMA REVISÃO DE LITERATURA
João Victor de Moraes Bueno, Ana Carolina de Moraes Bueno, Paulo Eduardo Macedo de Moraes Filho, et al.
Revista Ibero-Americana de Humanidades, Ciências e Educação (2023) Vol. 9, Iss. 5, pp. 1035-1045
Open Access | Times Cited: 2
Primary pulmonary Hodgkin’s lymphoma mimicking granulomatosis with polyangiitis – a case report of diagnostic and therapeutic dilemmas
Lucjan Sławiński, Julia Sołek, Joanna Miłkowska-Dymanowska, et al.
Współczesna Onkologia (2023) Vol. 27, Iss. 2, pp. 113-117
Open Access | Times Cited: 2
Synthesis and application of small molecules approved for the treatment of lymphoma
Yuanyuan Guo, Jingyi Zhang, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115835-115835
Closed Access | Times Cited: 2
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
Arina Martynchyk, Rakin Chowdhury, Eliza A. Hawkes, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5217-5217
Open Access | Times Cited: 2
Systemic Inflammation Score for Predicting Radiation-Induced Trismus and Osteoradionecrosis of the Jaw Rates in Locally Advanced Nasopharyngeal Carcinoma Patients
Efsun Somay
International Journal of Hematology and Oncology (2023) Vol. 33, Iss. 3, pp. 158-169
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top